Results

Total Results: 1,147 records

Showing results for "event".

  1. www.uspreventiveservicestaskforce.org/uspstf/document/update-on-the-methods-of-the-us-preventive-services-task-force-estimating-certainty-and-magnitude-of-net-bene%EF%AC%81t/carotid-artery-stenosis-screening-december-2007
    December 15, 2007 - the number of people who would need to be treated for some defined period to prevent 1 adverse health event … number of people who would need to be screened for some defined period to prevent 1 adverse health event … number of people who would need to be treated or screened for a defined time to cause 1 adverse health event
  2. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/bacterial-vaginosis-in-pregnancy-to-prevent-preterm-delivery-screening
    April 07, 2020 - than 34 weeks’ gestation among a subgroup of 22 participants with bacterial vaginosis and observed 1 event … 57 Consistent; imprecise u Although RCTs were mostly of good methodological quality, adverse event … range of indications; not specific to women with bacterial vaginosis Abbreviations: AE, adverse event
  3. www.uspreventiveservicestaskforce.org/home/getfilebytoken/efwy72cuMdhcF2jotkhTzC
    March 29, 2019 - Screening for HIV Infection: US Preventive Services Task Force Recommendation Statement Screening for HIV Infection US Preventive Services Task Force Recommendation Statement US Preventive Services Task Force IMPORTANCE Approximately 1.1 million persons in the United States are currently living with HIV, and more th…
  4. www.uspreventiveservicestaskforce.org/home/getfilebytoken/EppFbhnDEX5UtYWrTkLEhT
    March 01, 2007 - However, when event rates are low, as was the case in our review, the odds ratio provides a close approximation … Long-Term Arthritis Safety Study (CLASS) (74), Therapeutic Arthritis Research and Gastro- intestinal Event … lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event
  5. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary6/osteoporosis-screening-2011
    July 06, 2010 - between bisphosphonate use and atypical fractures of the subtrochanteric or diaphyseal femur, with an event … Fracture Outcome (95% CI) Vertebral Nonvertebral Hip Wrist Ankle Arcsine difference, 0 event … -0.01 (-0.04 to 0.02) -0.01 (-0.04 to 0.03) -0.03 (-0.09 to 0.02) Arcsine difference, 0 event … 0.03 (-0.05 to 0.00) -0.01 (-0.04 to 0.02) -0.01 (-0.04 to 0.03) -0.03 (-0.09 to 0.02) 0 eventEvent rates have been recalculated for 5 y.
  6. www.uspreventiveservicestaskforce.org/home/getfilebytoken/xt2Uhv4qyLUZ8o2HB_a4YQ
    July 01, 2013 - prolonged exposure to ART, the absolute risk for myocardial infarction was less than 0.6% and ab- solute event
  7. www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/screening-depression-suicide-risk-adults
    September 20, 2022 - Share to Facebook Share to Twitter Share to WhatsApp Share to E-mail Print in progress Draft Recommendation Statement Depression and Suicide Risk in Adults: Screening September 20, 2022 Recommendations made by th…
  8. www.uspreventiveservicestaskforce.org/home/getfilebytoken/7ZSKduUYHWKe7q_tTY9xbF
    April 01, 2013 - Thromboembolic event incidence was increased for ta- moxifen (RR, 1.93 [CI, 1.41 to 2.64]; 4 trials; … Coronary heart dis- ease event or stroke incidence was not increased in placebo- controlled trials (7 … Comparison of fracture, cardiovascular event, and breast cancer rates at 3 years in postmenopausal women … NR 59.8% (1615/2700) for 5 y 61.8% (1674/2708) for 5 y Discontinuation due to protocol specified event … NR NR 23.7% 19.7% NR NR NR NR 26.7% (721/2700) 25.3% (686/2708) Discontinuation due to adverse event
  9. www.uspreventiveservicestaskforce.org/home/getfilebytoken/-qaKjceN9BTy-oh7EFwXtk
    January 14, 2025 - (0.58-1.07)a 4 Fewer (9 fewer to 1 more) Harms of treatment (KQ5) Discontinuations due to adverse event … fewer to 9 more) 5 193 8826Denosumab 1.16 (0.87-1.54) 3 More (3 fewer to 11 more) Serious adverse event … fewer to 8 more) 6 2081 8934Denosumab 1.04 (0.97-1.12) 9 More (7 fewer to 28 more) Upper GI adverse event … 26 5873 22 172Bisphosphonates 1.02 (0.98-1.06) 5 More (5 fewer to 16 more) GI adverse event 4 15 … Postmenopausal women with osteoporosis or low bone mass; 1 study was only in men but had only 1 fracture event
  10. www.uspreventiveservicestaskforce.org/home/getfilebytoken/R_cAa3AjFGQ2np_aQnzQGA
    February 11, 2025 - (0.58-1.07)a 4 Fewer (9 fewer to 1 more) Harms of treatment (KQ5) Discontinuations due to adverse event … fewer to 9 more) 5 193 8826Denosumab 1.16 (0.87-1.54) 3 More (3 fewer to 11 more) Serious adverse event … fewer to 8 more) 6 2081 8934Denosumab 1.04 (0.97-1.12) 9 More (7 fewer to 28 more) Upper GI adverse event … 26 5873 22 172Bisphosphonates 1.02 (0.98-1.06) 5 More (5 fewer to 16 more) GI adverse event 4 15 … Postmenopausal women with osteoporosis or low bone mass; 1 study was only in men but had only 1 fracture event
  11. www.uspreventiveservicestaskforce.org/uspstf/recommendation/healthy-diet-and-physical-activity-counseling-for-cvd-prevention-in-adults
    June 15, 2012 - Seven case-crossover studies showed that the risk for a cardiac event (for example, sudden death or myocardial … However, the absolute risk for a cardiac event during physical activity is extremely low.
  12. www.uspreventiveservicestaskforce.org/uspstf/recommendation/healthy-diet-and-physical-activity-counseling-for-cvd-prevention-in-adults-2012
    June 15, 2012 - Seven case-crossover studies showed that the risk for a cardiac event (for example, sudden death or myocardial … However, the absolute risk for a cardiac event during physical activity is extremely low.
  13. www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/obstructive-sleep-apnea-adults-screening
    December 17, 2020 - in progress Draft Research Plan Obstructive Sleep Apnea in Adults: Screening December 17, 2020 Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health…
  14. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-nsaids/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication
    March 15, 2007 - However, when event rates are low, as was the case in our review, the odds ratio provides a close approximation … Celecoxib Long-term Arthritis Safety Study (CLASS), 74 Therapeutic Arthritis Research and Gastrointestinal Event … lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event
  15. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-nsaids/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication-2007
    March 15, 2007 - However, when event rates are low, as was the case in our review, the odds ratio provides a close approximation … Celecoxib Long-term Arthritis Safety Study (CLASS), 74 Therapeutic Arthritis Research and Gastrointestinal Event … lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event
  16. www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-adults
    June 20, 2023 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Recommendation Statement Depression and Suicide Risk in Adults: Screening June 20, 2023 Recommendations made by the USPSTF are independent of the U.S. government. …
  17. www.uspreventiveservicestaskforce.org/home/getfilebytoken/H6hac6B6NpcotwgSzpCt_b
    November 01, 2013 - However, adverse event rates were often incompletely reported, and the evi- dence is limited by a lack
  18. www.uspreventiveservicestaskforce.org/home/getfilebytoken/eSLqaKpvzhYRbQVeumNgSQ
    January 19, 2021 - Interventions for Tobacco Cessation in Adults, Including Pregnant Persons: Updated Evidence Report and Systematic Review for the USPSTF Interventions for Tobacco Cessation in Adults, Including Pregnant Persons Updated Evidence Report and Systematic Review for the US Preventive Services Task Force Carrie D. Patnode, P…
  19. www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/breast-cancer-medication-use-reduce-risk
    December 28, 2023 - Share to Facebook Share to X Share to WhatsApp Share to Email Print in progress Draft Research Plan Breast Cancer: Medication to Reduce Risk December 28, 2023 Recommendations made by the USPSTF are independent of the U.S. government. They shou…
  20. www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/breast-cancer-medication-use-reduce-risk
    March 21, 2024 - Share to Facebook Share to X Share to WhatsApp Share to Email Print in progress Final Research Plan Breast Cancer: Medication to Reduce Risk March 21, 2024 Recommendations made by the USPSTF are independent of the U.S. government. They shou…

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: